HTX provides a suite of programs that fund Medical and Assistive Technologies on a competitive basis. The HTX funding model emphasizes collaboration between industry and academic leaders.
To date HTX has received 273 expressions of interest (EOI), invited 160 full proposals and approved funding for over 70 projects since its inception in 2004. HTX has supported more than $16 million towards R&D projects led by Ontario-based SMEs, in partnership with publicly funded healthcare institutions; which includes the required matching funds from the MAT sector applicants, plus additional support from the program partners.
The PROGRAM will facilitate access to Ontario's health care system through supporting the implementation of innovative technologies in Ontario-based clinical institutions. For the participating clinical institution, the PROGRAM facilitates access to leading edge Medical and Assistive Technologies (MAT) at little to no direct financial cost. The long term goal is to support the procurement efforts of Ontario-based MAT SMEs through local customer validation vis-a-vis the technology assessment. The PROGRAM is not intended to directly fund technology development rather it is to support the uptake of developed innovative health technologies within clinical institutions, and as well enhance the export opportunities for the SME involved.
Quick facts:
- Maximum funding is $100,000
- Maximum HTX support is 50% of total project costs;
- Project must be completed within a 12 month period;
Deadline:
- Expressions of Interest will be accepted up to and including September 25, 2009.
Click here for HTAIP Guidelines
The Business Investment Program will fund business driven R&D that is undertaken by a team from a recognized publicly funded research institution in Ontario in collaboration with a partnering company. The PROGRAM will help to support the cost of the research at the publicly funded research institution and facilitate the transfer of intellectual property or other research outcomes to the partnering company.
Quick Facts:
- Maximum funding is $100,000
- Maximum HTX support is 50% of total project costs;
- Project must be completed on or before 18 month period;
Click here for BIP Guidelines and Application Forms
A pilot PROGRAM for clinical trials (testing) of Ontario innovative products in the field of Medical and Assistive Technologies (MAT), with priority to assist SME and relevant technology developers, has been established in a collaborative venture among YORKbiotech and htx.ca - The Health Technology Exchange (HTX). Letters of Intent (LOIs) are invited from suitably qualified organizations that wish to be considered for support via this PROGRAM.
Quick facts:
- Restricted to devices that are not likely to require significant regulatory approval (i.e., Class 1 devices)
- Available pool of funds for this pilot project is up to $200,000
- Successful applicants will be expected to match the amount of any grant made available to them.
Click here for CVP Guidelines
A pilot PROGRAM for clinical validation (testing) of Ontario innovative products in the field of Medical and Assistive Technologies (MAT), with priority to assist SME and relevant technology developers has been established in a collaborative venture among BioDiscovery Toronto (BDT) and htx.ca - The Health Technology Exchange (HTX). Letters of Intent (LOIs) are invited from suitably qualified organizations that wish to be considered for support via this PROGRAM. The PROGRAM is restricted to devices that are not likely to require significant regulatory approval (i.e. Class 1 devices). The available pool of funds for this pilot project is currently $200,000. It is anticipated that several products will be supported from the available pool of funds. Successful applicants will be expected to match the amount of any grant made available to them.
Quick Facts:
- Restricted to devices that are not likely to require significant regulatory approval (i.e., Class 1 devices)
- Available pool of funds for this pilot project is currently $200,000
- Successful applicants will be expected to match the amount of any grant made available to them.
Click here for CVP Guidelines
A pilot PROGRAM for clinical trials (testing) of Ontario innovative products in the field of Medical and Assistive Technologies (MAT), to assist SMEs, has been established in a collaborative venture among the Golden Horseshoe Biosciences Network (GHBN), Hamilton Health Sciences (HHS), htx.ca - The Health Technology Exchange (HTX) and McMaster University. Letters of Intent (LOIs) are invited from suitably qualified organizations that wish to be considered for support via this PROGRAM.
Quick Facts:
- Restricted to devices that are not likely to require significant regulatory approval (i.e., Class 1 devices)
- Available pool of funds for this pilot project is currently $200,000
- Successful applicants will be expected to match the amount of any grant made available to them.
Click here for Guidelines